heart attack

Pharma

FDA approves Lilly's Mounjaro to reduce risk of cardio events

The FDA has signed off on a label expansion for Eli Lilly's Mounjaro to reduce the risk of heart attack or stroke in at-risk adults with type 2 diabetes.

Kevin Dunleavy Aug 28, 2026 10:52am

UK cost watchdog clears Novo's Wegovy for cardio risk reduction

Apr 1, 2026 9:38am

Fierce Biotech

How GLP-1s help the heart relax: study

Mar 2, 2026 7:01pm

Amgen's Repatha meets the mark in CV primary prevention trial

Oct 2, 2025 11:26am

Amgen Making of a Heart Attack documentary

Amgen tackles dangers of LDL cholesterol in 1st documentary film

Jul 9, 2025 7:55am

FDA approves Roche's heart attack med TNKase to treat stroke

Mar 3, 2025 3:19pm